Stay updated on Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.

Latest updates to the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page
- Check7 days agoChange DetectedThe revision label at the bottom of the page changed from v3.6.4 to v3.6.5, indicating a new page version. This is a standard site update and does not alter study details.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedRevision label updated from v3.6.3 to v3.6.4. The page content and functionality remain the same for users.SummaryDifference0.0%

- Check28 days agoNo Change Detected
- Check42 days agoChange DetectedFooter revision updated from v3.6.2 to v3.6.3. This reflects a minor version update of the page rather than changes to the study details or substantive content.SummaryDifference0.0%

- Check50 days agoChange DetectedThe page now displays the updated revision tag (v3.6.2) indicating a newer build of the page, rather than a change to study details.SummaryDifference0.0%

- Check64 days agoChange DetectedNew navigation/help items were added (How to Read a Study Record, Common Questions, How to Join a Study, Intervention/Treatment) and a recruitment status label 'No longer looking for participants', along with an updated site revision tag 'Revision: v3.6.0'. The removal of the 'Intervention / Treatment' label and the older 'Revision: v3.5.5' entry indicates a UI cleanup and version update.SummaryDifference0.4%

- Check71 days agoChange DetectedThe page now displays Revision: v3.5.5 instead of Revision: v3.5.4, indicating an updated site build.SummaryDifference0.0%

Stay in the know with updates to Rebastinib with Paclitaxel in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Rebastinib with Paclitaxel in Solid Tumors Clinical Trial page.